MedPace Holdings IPO Advisory
Share this IPO Profile:
Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
MedPace Holdings | MEDP - NASDAQ |
$20.00-$23.00 |
$23.00 |
$28.15 | 7 million | 8/11/2016 |
Jefferies, Credit Suisse, UBS Investment Bank, Wells Fargo Securities |
Co-Manager(s): Baird, William Blair |
Health Care |
Filing(s): Filed 2016-06-24 Terms Added 2016-08-01
|
For IPO Boutique's "scale of 1 to 5" BUY rating on MedPace Holdings, and our comprehensive analysis, click "Buy Market Research".
MedPace Holdings Quote & Chart - Click for current quote -
MEDP
About MedPace Holdings (adapted from MedPace Holdings prospectus):
They are one of the worlds leading clinical contract research organizations, or CROs, by revenue, solely focused on providing scientifically-driven outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "MEDP" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
© 2005 - 2024 IPO Boutique. All Rights Reserved